Back
Day Range
$23.21
$24.50
52-Week Range
$10.44
$47.65
Volume
1,238,360
50D / 200D Avg
$29.55
/
$29.16
Prev Close
$24.07
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -10.1 | 0.4 |
| P/B | 2.4 | 2.9 |
| ROE % | -36.9 | 3.8 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$46.00
+94.5%
Low: $30.00
High: $56.00
Forward EPS
-$2.19
Est. Revenue
560000
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$5.23
$2.67 – $13.20
|
1.3 B | 1 |
| FY2029 |
$2.48
$1.26 – $6.25
|
750 M | 1 |
| FY2028 |
-$0.94
-$1.58 – -$0.28
|
250 M | 5 |
Key Takeaways
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -142.43M
PEG of 0.42 suggests growth is underpriced
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-36.91%
ROIC-19.79%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.00
Current Ratio43.76
Interest Coverage0.00
Valuation
P/E Ratio
-10.14
P/B Ratio2.42
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -154.65M |
| ROE | -36.91% | ROA | -23.37% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -142.43M |
| ROIC | -19.79% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 43.76 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -10.14 | P/B Ratio | 2.42 |
| P/S Ratio | N/A | PEG Ratio | 0.42 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.57B | Enterprise Value | 1.39B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -154.65M | -177.81M | -71.90M | -29.80M | -19.41M |
| EPS (Diluted) | -2.29 | -3.66 | -1.99 | -5.77 | -3.89 |
| Gross Profit | -59,000.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -170.60M | -192.40M | -84.66M | -31.48M | -18.73M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 661.81M | 205.90M | 251.64M | 114.44M | 11.13M |
| Total Liabilities | 15.11M | 14.65M | 10.48M | 166.71M | 34.05M |
| Shareholders' Equity | 646.69M | 191.26M | 241.15M | -52.27M | -22.93M |
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash & Equivalents | 172.92M | 114.09M | 49.30M | 87.70M | 10.61M |
| Current Assets | 661.39M | 205.35M | 249.10M | 112.81M | 11.12M |
| Current Liabilities | 15.11M | 14.65M | 10.48M | 8.07M | 5.05M |